To unravel the potential molecular mechanism underlying B-Myb-promoted malignant phenotype in CRC cells, we conducted RNA-seq analysis to determine the gene expression profile changes at whole genomic level in stable B-Myb overexpression and knockdown cells. The gene discussed is MYBL2; the disease is colorectal carcinoma.